FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Moshe Rehavi

Research Profile

Chemicals & Drugs

Living Beings

Rats

Anatomy

Phenomena

Protein Binding

Co-author Network

Publications

TOP 3
Keren Oved; Metsada Pasmanik-Chor; Moshe Rehavi; Noam Shomron; Julia C Stingl; Ayelet Morag; Varda Oron-Karni; David Gurwitz
Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers.
Ravid Doron; Karen Lavi; Dafna Lotan; Anat Rak-Rabl; Adi Raskin-Ramot; Moshe Rehavi
Anxiolytic effects of a novel herbal treatment in mice models of anxiety.
Yona Bismuth-Evenzal; Yehudit Gonopolsky; David Gurwitz; Iulian Iancu; Abraham Weizman; Moshe Rehavi
Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Moshe Rehavi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Keren Oved; Metsada Pasmanik-Chor; Moshe Rehavi; Noam Shomron; Julia C Stingl; Ayelet Morag; Varda Oron-Karni; David Gurwitz
Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers.
Pharmacogenomics 2012;13(10):1129-39.
2012: Ravid Doron; Karen Lavi; Dafna Lotan; Anat Rak-Rabl; Adi Raskin-Ramot; Moshe Rehavi
Anxiolytic effects of a novel herbal treatment in mice models of anxiety.
Life sciences 2012;90(25-26):995-1000.
2012: Yona Bismuth-Evenzal; Yehudit Gonopolsky; David Gurwitz; Iulian Iancu; Abraham Weizman; Moshe Rehavi
Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
Journal of affective disorders 2012;136(1-2):99-103.
2011: Gil Zalsman; Abraham Weizman; Nathaniel Laor; Moshe Rehavi; Netta Roz; Paz Toren
Altered affinity of the platelet vesicular monoamine transporter 2 to dihydrotetrabenazine in children with major depression.
Journal of neural transmission (Vienna, Austria : 1996) 2011;118(9):1383-7.
2011: Gil Zalsman; Robert Vermeiren; Abraham Weizman; Dorit Aslanov-Farbstein; Nathaniel Laor; Moshe Rehavi; Netta Roz; Paz Toren
Platelet vesicular monoamine transporter 2 density in the disruptive behavior disorders.
Journal of child and adolescent psychopharmacology 2011;21(4):341-4.
2011: Ayelet Morag; Metsada Pasmanik-Chor; Varda Oron-Karni; Moshe Rehavi; Julia C Stingl; David Gurwitz
Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker.
Pharmacogenomics 2011;12(2):171-84.
2010: Yona Bismuth-Evenzal; Netta Roz; David Gurwitz; Moshe Rehavi
N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.
Biochemical pharmacology 2010;80(10):1546-52.
2010: Y Simchon; Abraham Weizman; Moshe Rehavi
The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010;20(10):714-20.
2010: Avi Valevski; Eran Pickholtz; Netta Roz; Abraham Weizman; Moshe Rehavi
Lack of modulatory effect of short-term repeated electroconvulsive therapy on platelet vesicular monoamine transporter 2 (VMAT2) in depressed patients.
Journal of neural transmission (Vienna, Austria : 1996) 2010;117(7):881-5.
2010: Ayelet Morag; Julia Kirchheiner; Moshe Rehavi; David Gurwitz
Human lymphoblastoid cell line panels: novel tools for assessing shared drug pathways.
Pharmacogenomics 2010;11(3):327-40.
2010: Vered Dror; Sarah Eliash; Moshe Rehavi; Yaniv Assaf; Inbal E Biton; Aviva Fattal-Valevski
Neurodegeneration in thiamine deficient rats-A longitudinal MRI study.
Brain research 2010;1308():176-84.
2009: Sarah Eliash; Vered Dror; S Cohen; Moshe Rehavi
Neuroprotection by rasagiline in thiamine deficient rats.
Brain research 2009;1256():138-48.
2008: Adi Malkoff; Abraham Weizman; Illana Gozes; Moshe Rehavi
Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidol.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(11):1563-71.
2008: Michal Reichenstein; Moshe Rehavi; Albert Pinhasov
Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action.
Journal of molecular neuroscience : MN 2008;36(1-3):330-8.
2008: Maytal Shabat-Simon; Dino Levy; Alon Amir; Moshe Rehavi; Abraham Zangen
Dissociation between rewarding and psychomotor effects of opiates: differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(34):8406-16.
2007: David H Ben-Dor; Sharon Zimmerman; Jonathan Sever; Netta Roz; Alan Apter; Moshe Rehavi; Abraham Weizman
Reduced platelet vesicular monoamine transporter density in Tourette's syndrome pediatric male patients.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(8):523-6.
2007: Karin Schwartz; I Herman; G Peer; Abraham Weizman; Moshe Rehavi
Elevated platelet vesicular monoamine transporter 2 in former heroin addicts maintained on methadone.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(2):281-4.
2007: Karin Schwartz; Rachel Nachman; M Yossifoff; R Sapir; Abraham Weizman; Moshe Rehavi
Cocaine, but not amphetamine, short term treatment elevates the density of rat brain vesicular monoamine transporter 2.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(4):427-30.
2006: Tal Barkan; Avi Peled ; Ilan Modai; Peretz Barak; Abraham Weizman; Moshe Rehavi
Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patients.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2006;16(8):572-9.
2006: Karin Schwartz; Abraham Weizman; Moshe Rehavi
The effect of psychostimulants on [3H]dopamine uptake and release in rat brain synaptic vesicles.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(9):1347-52.
2006: Tal Barkan; Avi Peled ; Ilan Modai; Abraham Weizman; Moshe Rehavi
Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individuals.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2006;16(6):429-36.
2006: Tal Barkan; Haggai Hermesh; Sofi Marom; David Gurwitz; Abraham Weizman; Moshe Rehavi
Serotonin uptake to lymphocytes of patients with social phobia compared to normal individuals.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2006;16(1):19-23.
2005: David Gurwitz; Moshe Rehavi
[Pharmacogenetics: towards personalized medicine].
Harefuah 2005;144(10):711-6, 750.
2005: Karin Schwartz; Iulian Iancu; Rafael Stryjer; Joseph Chelben; Moshe Kotler; Abraham Weizman; Moshe Rehavi
Reduced platelet vesicular monoamine transporter density in smoking schizophrenia patients.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(5):557-61.
2005: Neil Laufer; Michal Zucker; Haggai Hermesh; Sofi Marom; Royi Gilad; Vered Nir; Abraham Weizman; Moshe Rehavi
Platelet vesicular monoamine transporter density in untreated patients diagnosed with social phobia.
Psychiatry research 2005;136(2-3):247-50.
2005: Karin Schwartz; Abraham Weizman; Moshe Rehavi
Decreased platelet vesicular monoamine transporter density in habitual smokers.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(2):235-8.
2005: Michal Zucker; Abraham Weizman; Moshe Rehavi
Repeated swim stress leads to down-regulation of vesicular monoamine transporter 2 in rat brain nucleus accumbens and striatum.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(2):199-201.
2005: Paz Toren; Moshe Rehavi; Anat Luski; Netta Roz; Nathaniel Laor; Michal Lask; Abraham Weizman
Decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2005;15(2):159-62.
2005: Daphna Joel; Julia T Doljansky; Netta Roz; Moshe Rehavi
Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder.
Neuroscience 2005;130(1):25-36.
2004: Netta Roz; Moshe Rehavi
Hyperforin depletes synaptic vesicles content and induces compartmental redistribution of nerve ending monoamines.
Life sciences 2004;75(23):2841-50.
2004: Tal Barkan; David Gurwitz; Galit Levy; Abraham Weizman; Moshe Rehavi
Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2004;14(3):237-43.
2003: Lee Zuckerman; Moshe Rehavi; Rachel Nachman; Ina Weiner
Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(10):1778-89.
2003: Netta Roz; Moshe Rehavi
Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membrane.
Life sciences 2003;73(4):461-70.
2003: Karin Schwartz; Gal Yadid; Abraham Weizman; Moshe Rehavi
Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression.
Brain research 2003;965(1-2):174-9.
2003: David Gurwitz; Abraham Weizman; Moshe Rehavi
Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine.
Trends in pharmacological sciences 2003;24(3):122-5.
2002: Michal Zucker; Alex Aviv; Assaf Shelef; Abraham Weizman; Moshe Rehavi
Elevated platelet vesicular monoamine transporter density in untreated patients diagnosed with major depression.
Psychiatry research 2002;112(3):251-6.
2002: Netta Roz; Yehuda Mazur; Amiram Hirshfeld; Moshe Rehavi
Inhibition of vesicular uptake of monoamines by hyperforin.
Life sciences 2002;71(19):2227-37.
2002: Michal Zucker; Avi Valevski; Abraham Weizman; Moshe Rehavi
Increased platelet vesicular monoamine transporter density in adult schizophrenia patients.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2002;12(4):343-7.
2002: Moshe Rehavi; Netta Roz; Abraham Weizman
Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2002;12(3):261-8.
2001: Michal Zucker; Abraham Weizman; Moshe Rehavi
Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.
Life sciences 2001;69(19):2311-7.
2001: Irit Gil-Ad; Biana Shtaif; Rina Eshet; Rachel Maayan; Moshe Rehavi; Abraham Weizman
Effect of dehydroepiandrosterone and its sulfate metabolite on neuronal cell viability in culture.
The Israel Medical Association journal : IMAJ 2001;3(9):639-43.
2001: Michal Zucker; Abraham Weizman; Daniella Harel; Moshe Rehavi
Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat Substantia nigra and prefrontal cortex induced by psychotropic drugs.
Neuropsychobiology 2001;44(4):187-91.
2000: Moshe Rehavi; Gitit Attali; Irit Gil-Ad; Abraham Weizman
Suppression of serum gonadal steroids in rats by chronic treatment with dopamine and serotonin reuptake inhibitors.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2000;10(3):145-50.
1998: Zipora Speiser; O Katzir; Moshe Rehavi; T Zabarski; S Cohen
Sparing by rasagiline (TVP-1012) of cholinergic functions and behavior in the postnatal anoxia rat.
Pharmacology, biochemistry, and behavior 1998;60(2):387-93.
1998: Moshe Rehavi; M Goldin; Netta Roz; Abraham Weizman
Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones.
Brain research. Molecular brain research 1998;57(1):31-7.
1997: Gitit Attali; Abraham Weizman; Irit Gil-Ad; Moshe Rehavi
Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters.
Brain research 1997;756(1-2):153-9.
1996: Paz Toren; Jehoshua Dor; Moshe Rehavi; A Weizman
Hypothalamic-pituitary-ovarian axis and mood.
Biological psychiatry 1996;40(10):1051-5.
1996: Ronit Weizman; Nathaniel Laor; A Schujovitsky; Leo Wolmer; P Abramovitz-Schnaider; A Freudstein-Dan; Moshe Rehavi
Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment.
Psychiatry research 1996;63(2-3):143-50.
1996: S Eyal; Abraham Weizman; Paz Toren; Y Dor; Roberto Mester; Moshe Rehavi
Chronic GnRH agonist administration down-regulates platelet serotonin transporter in women undergoing assisted reproductive treatment.
Psychopharmacology 1996;125(2):141-5.
1996: Paz Toren; Jehoshua Dor; Roberto Mester; Tamar Mozes; Rachel Blumensohn; Moshe Rehavi; Abraham Weizman
Depression in women treated with a gonadotropin-releasing hormone agonist.
Biological psychiatry 1996;39(5):378-82.
1996: I Gordon; Ronit Weizman; Moshe Rehavi
Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.
European journal of pharmacology 1996;298(1):27-30.
1995: I Gordon; Ronit Weizman; E Rosenne; Moshe Rehavi
Developmental and age-related alterations in rat brain presynaptic dopaminergic mechanisms.
Brain research. Developmental brain research 1995;85(2):225-8.
1995: I Gordon; Ronit Weizman; Moshe Rehavi
[3H]GBR 12935 labels mainly the piperazine acceptor site in the rat prefrontal cortex.
Brain research 1995;674(2):205-10.
1995: I Gordon; Matti Mintz; E Rosenne; Moshe Rehavi
Long-term effects of amygdaloid kindling on striatal dopaminergic terminals.
Brain research bulletin 1995;36(3):235-9.
1994: Matti Mintz; I Gordon; N Roz; Moshe Rehavi
The effect of repeated amphetamine treatment on striatal DA transporter and rotation in rats.
Brain research 1994;668(1-2):239-42.
1994: S Adlersberg; Paz Toren; Roberto Mester; Moshe Rehavi; Phil Skolnick; Abraham Weizman
Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants.
Clinical neuropharmacology 1994;17(3):294-7.
1994: I Gordon; Moshe Rehavi; Matti Mintz
Bilateral imbalance in striatal DA-uptake controls rotation behavior.
Brain research 1994;646(2):207-10.
1994: I Gordon; Ronit Weizman; Moshe Rehavi
[3H]GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitors.
Life sciences 1994;55(3):189-99.
1993: Moshe Rehavi; Z Jerushalemi; A Aviv; Nathaniel Laor; E Podliszewski; L Karp; S Shavit; Ronit Weizman
Interaction between antidepressants and phosphoinositide signal transduction system in human platelets.
Biological psychiatry 1993;33(1):40-4.
1992: Ronit Weizman; Irit Gil-Ad; L Karp; Nathaniel Laor; Y Barber; Moshe Rehavi
Platelet imipramine binding and plasma cortisol levels in Israeli civilians during the Gulf War.
Biological psychiatry 1992;32(2):170-8.
1992: A Weizman; A Mandel; Y Barber; Raphael Weitz; A Cohen; R Mester; Moshe Rehavi
Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder.
Biological psychiatry 1992;31(7):705-11.
1991: Zipora Speiser; I Gordon; Moshe Rehavi; S Gitter
Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists.
European journal of pharmacology 1991;195(1):75-83.
1991: Moshe Rehavi; Edit Schnitzer
Long-term desipramine or chlorpromazine treatment and rat brain N-methyl-D-aspartate receptor.
Journal of basic and clinical physiology and pharmacology 1991;2(1-2):111-21.
1988: Moshe Rehavi; R Carmi; Abraham Weizman
Tricyclic antidepressants and calcium channel blockers: interactions at the (-)-desmethoxyverapamil binding site and the serotonin transporter.
European journal of pharmacology 1988;155(1-2):1-9.
1988: Abraham Weizman; E Bernhout; Raphael Weitz; S Tyano; Moshe Rehavi
Imipramine binding to platelets of children with attention deficit disorder with hyperactivity.
Biological psychiatry 1988;23(5):491-6.